[Lymphatic system changes after the endolymphatic administration of an oil-based solution of dibunol].
Endolymphatic infusions of a 10 percent solution of dibunol in iodolipol or chromolymphotrast were given for prevention of lymphogenic dissemination of rectal cancer. Certain changes in X-ray pattern of lymphogenic metastases developed due to prolonged intravascular retention of the contrast agent. Under such conditions metastatic lesions took the form of collateral lymph flow development and enlargement and deformation of lymph nodes. The diagnostic value of lymphography appears to be still higher when several symptoms of metastatic involvement of the lymphatic system are in evidence.
D000230:Adenocarcinoma / Q000000981:diagnostic imaging / Q000628:therapy; D002288:Adenocarcinoma, Mucinous / Q000000981:diagnostic imaging / Q000628:therapy; D000970:Antineoplastic Agents / Q000008:administration & dosage*; D002084:Butylated Hydroxytoluene / Q000008:administration & dosage*; D003287:Contrast Media / Q000008:administration & dosage; D006801:Humans; D007272:Injections, Intralymphatic; D008207:Lymphatic Metastasis; D008208:Lymphatic System / Q000187:drug effects*; D008220:Lymphography; D009821:Oils / Q000008:administration & dosage; D010592:Pharmaceutic Aids / Q000008:administration & dosage; D011300:Preoperative Care; D012004:Rectal Neoplasms / Q000000981:diagnostic imaging / Q000628:therapy; D012995:Solubility
D000970:Antineoplastic Agents; D003287:Contrast Media; D009821:Oils; D010592:Pharmaceutic Aids; D002084:Butylated Hydroxytoluene
Izmeneniia limfaticheskoĭ sistemy pri éndolimfaticheskom vvedenii maslianogo rastvora dibunola.